Preparing Research Experience

Skip to main content

Lab Tested

Reta GLP-3 30 MG research product

Quality documentationBrowse available batch documentation in our COA library.

Weight Management Research

Reta GLP-3 30 MG

(RETATRUTIDE; GLP-1/GIP/GLUCAGON RECEPTOR AGONIST)

In Stock

Everwell Peptides Reta GLP-3 30MG is a higher-measurement research format studied in controlled laboratory models involving GLP-1, GIP, and glucagon receptor signaling. Investigations commonly focus on metabolic communication, energy-balance pathways, and body-composition markers. For research use only.

Format
Vials
Research Qty.
30 MG
Purity
Documentation Varies
Product ID
EW-0004
Unit Price$389.99
1 Item Total$389.99
Browse COAs
Available Dosages

Available to order. Inventory is reserved only after payment.

Research use only. Not for human or animal consumption, ingestion, administration, diagnostic use or therapeutic use.

Research Product Information

Reta GLP-3 Details

Review identification, documentation and recommended laboratory handling information before ordering.

01

Research Overview

About Reta GLP-3

Everwell Peptides Reta GLP-3 30MG is a higher-measurement research format studied in controlled laboratory models involving GLP-1, GIP, and glucagon receptor signaling. Investigations commonly focus on metabolic communication, energy-balance pathways, and body-composition markers. For research use only.

Everwell Peptides supplies this material strictly for research and analytical applications. Product information is provided for identification and documentation and is not a claim of clinical efficacy.

02

Product Specifications

30 MG Research Product

Product
Reta GLP-3
Quantity
30 MG
Type
Vials
Documentation
See COA catalog
03

Laboratory Handling

Storage & Care

  • Keep sealed in a cool, dry and controlled laboratory environment.
  • Protect from direct light, heat and repeated temperature changes.
  • Follow batch documentation and validated facility procedures.
  • Restrict access to qualified research personnel.
0